Jacob Asset Management of New York »

Esperion Therapeutics shares owned by Jacob Asset Management of New York

Quarter-by-quarter ownership of Esperion Therapeutics (ESPR) shares owned by Jacob Asset Management of New York from 13F filings

Historical chart of Jacob Asset Management of New York investment in Esperion Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Esperion Therapeutics held by Jacob Asset Management of New York consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Esperion Therapeutics by Jacob Asset Management of New York

Quarter filed Position value Share count Share price at filing
2023-09-30 $59k 60k 0.98
2021-09-30 $573k 48k 12.05
2021-06-30 $1.4M 64k 21.15
2021-03-31 $1.8M 64k 28.04
2020-12-31 $817k 31k 25.99

More positions owned by Jacob Asset Management of New York

Draftkings Com Cl A (DKNG)
Inspired Entmt (INSE)
Identiv Com New (INVE)
Cloudflare Cl A Com (NET)
Optimizerx Ord (OPRX)
Cantaloupe (CTLP)
Lantronix Com New (LTRX)
Doximity Cl A (DOCS)
Twilio Cl A (TWLO)
Mongodb Cl A (MDB)
Immersion Corporation (IMMR)
Block Cl A (SQ)
Hashicorp Com Cl A (HCP)
Digital Turbine Com New (APPS)
Porch Group (PRCH)

View all positions for Jacob Asset Management of New York

Top funds holding Esperion Therapeutics

Daniel D. Thurber
Vanguard Group
Bellevue Group
Meditor
Millennium Management
Two Sigma Investments
Two Sigma Advisers
Jpmorgan Chase & Co
Tang Capital Management
D. E. Shaw & Co
Walleye Trading
GSA Capital Partners
Schonfeld Strategic Advisors
Jacobs Levy Equity Management
Goldman Sachs Group

View all funds holding Esperion Therapeutics